Skip to content
Stop using now Drug recall · FDA · Published November 21, 2013

B. Braun Recalls Cefoxitin/Dextrose IV Bags Due to Particulate Matter

B. Braun Medical Inc recalls specific lots of Cefoxitin for Injection and Dextrose Injection due to visible particulate matter found in reserve samples.

🇺🇸 FDA recall #D-1264-2014DrugB. Braun Medical Inc ›
Take action

Contact the company

Recalling firmB. Braun Medical Inc2525 McGaw Ave · Irvine, CA 92614-5841
✎ GovInfoNow plain-language explainer

B. Braun Medical Inc is recalling several injectable products, specifically Cefoxitin for Injection and Dextrose Injection, because visible particulate matter was found in reserve sample units. The recall affects 22,584 units distributed nationwide, in Puerto Rico, and in Spain. This issue involves Catalog No. 3123-11 with NDC 0264-3123-11. Read more at govinfonow.com/recall/46386-b-braun-medical-inc-recalls-cefoxitin-for-injection-and-dextrose.

Source Summary by GovInfoNow · govinfonow.com/recall/46386-b-braun-medical-inc-recalls-cefoxitin-for-injection-and-dextrose · Updated October 13, 2026 · FDA enforcement record: FDA #D-1264-2014

Cite this page

“B. Braun Recalls Cefoxitin/Dextrose IV Bags Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46386-b-braun-medical-inc-recalls-cefoxitin-for-injection-and-dextrose. Based on FDA recall #D-1264-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1264-2014%22&limit=1).

B. Braun Medical Inc. recalled Cefoxitin for Injection and Dextrose Injection due to visible particulate matter, the Food and Drug Administration said on Nov. 21, 2013. The agency announced the Class I recall of 22,584 units distributed nationwide, in Puerto Rico and Spain.

How to tell if you have it

  • Brand: B. Braun Medical Inc
  • Product: Cefoxitin for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container
  • Catalog No.: 3123-11
  • NDC: 0264-3123-11
  • Lot#: H3E507
  • Expiration: 11/14

The hazard

The recall addresses the presence of visible particulate matter found in reserve sample units of the injectable product. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.

Context

GovInfoNow's records show B. Braun Medical Inc. has issued 66 other recalls since Oct. 15, 2013. Recent similar recalls include a Sodium Chloride Injection recall for particulate matter on Aug. 19, 2026, and a Lactated Ringer's Injection recall for particulate matter on Aug. 12, 2026. Other recent recalls of similar products include an Apollo Care SEMAGLUTIDE Vial Recall (July 29, 2026), an American Regent Nitroglycerin Injection Recall (July 24, 2026), and an American Regent Multrys IV injection recall (July 24, 2026).

How to tell if you have this one

Check for Cefoxitin for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog No. 3123-11, NDC 0264-3123-11. Look specifically for Lot# H3E507 with an expiration date of 11/14.

  • Brand
    B. Braun Medical Inc
  • Category
    Drug
FDA recall event · 12 products

All 12 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Terminated
  • Distribution
    Nationwide, Puerto Rico and Spain
Recall numberProduct, codes & lotsQuantityNDC
D-1264-2014Cefoxitin for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog No. 3123-11, For IV Use Only, Single Use, Sterile, Rx Only, B Braun Medical Inc, Irvine CA 92614-5895, NDC 0264-3123-11; Lot# H3E507, Exp 11/1422,584 units0264-3123-11, 0264-3125-11
D-1265-20140.9 % Sodium Chloride Injection USP in PAB 50 mL partial fill in 100 mL PAB Container, Catalog No. S8004-5384, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-1800-31; Lot# J2P912, Exp 02/1453,592 units0264-1800-36, 0264-1800-31, 0264-1800-32
D-1266-2014Ceftriaxone for Injection and Dextrose Injection, 1 g in Duplex, 50 mL Container, Catalog Number 3153-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895; Lot# H3B702, Exp 02/1532,376 units—
D-1267-2014Cefepime for Injections USP and Dextrose Injection USP, 1 g in Duplex, 50 mL Container, Catalog Number 3193-11, For IV Use Only, Single Dose, Sterile, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3193-11; Lot# H2L712, Exp 09/1422,248 units0264-3193-11, 0264-3195-11
D-1268-2014Cefazolin for Injection USP and Dextrose Injections USP, 1 g in Duplex, 50 mL Container, Catalog Number 3103-11, For IV Use Only, Sterile, Single Dose, Rx Only, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-3103-11; Lot# H2S725, H2S726, Exp 07/14; H3D724, Exp 11/14; H3E724, Exp 12/14; Lot# H3H507, Exp 01/15136,392 units0264-3103-11, 0264-3105-11, 0264-3107-11
D-1269-2014Cefazolin for Injection USP and Dextrose Injection USP, 2 g in Duplex, 50 mL Container, Catalog Number 3105-11, Rx Only, B Braun Medical Inc., Irvine CA 92614, NDC 0264-3105-11; Lot# H2S723, Exp 07/14; H3H711, Exp 01/1542,576 units0264-3103-11, 0264-3105-11, 0264-3107-11
D-1270-20140.9 % Sodium Chloride Injection USP, 1000 mL, Catalog No. S4000-SS, Rx Only, Sterile, Single Dose Container, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-4000-55; Lot# J0B003, Exp 02/141302 units—
D-1271-20146.9% FreAmine HBC (Amino Acid Injection), partial fill container 750 mL in a 1000 mL container, Catalog No. S9350-58SS, Sterile, Single dose container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-9350-55; Lot# J2H002, Exp 06/14; J2S018, Exp 12/144614 units—
D-1272-201415% Amino Acids Injection PBP Glass, 1000 mL, Catalog No. S3200-SS, Pharmacy Bulk Package, Not For Direct Infusion, For Intravenous Use, Sterile, Single Dose Container, Rx Only, B Braun Medical Inc., Irvine, CA 92614-5895, NDC 0264-3200-55; Lot# J2J012, Exp 01/14; J3B002, Exp 08/1418,288 units—
D-1273-2014TrophAmine (10% Amino Acid Injection), 500 mL Container, Rx Only, Catalog No. S9341-SS, Sterile, Single Dose Container, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-9341-55; Lot# J3A028, Exp 07/1417,544 units—
D-1274-2014ProcalAmine (3% Amino Acid and 3% Glycerin Injection with Electrolytes) 1000 mL Container, Rx Only, Catalog No. S9050, Sterile, Single Dose Container, B Braun Medical Inc., Irvine CA 92614-5895, NDC 0264-1915-07; Lot# J2K023, Exp 02/1418,090 units—
D-1275-2014Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No. S9432, Rx Only, Sterile, B Braun Medical Inc., Irvine CA 92614-5895, In Canada Dist by: B Braun Medical Inc., Scarborough, Ontario M1H 2W4, NDC 0264-1943-20, Canada DIN 01924311; Lot# J3B007, Exp 08/145,592 units—
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use the recalled injectable products due to the presence of visible particulate matter.

  2. Contact your provider

    Healthcare providers should contact B. Braun Medical Inc for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide, Puerto Rico and Spain” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Nov 21, 201312. FDA classified it Class I: Apr 25, 201423. Published in FDA’s Enforcement Report: May 7, 201434. FDA terminated the recall: Dec 4, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1264-2014 (November 21, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1264-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA